Cursive
UK AI startup developing continuous-learning AI agents, backed by the UK Sovereign AI Fund.
Last refreshed: 19 April 2026 · Appears in 1 active topic
What are continuous-learning AI agents and why did the UK back Cursive?
Timeline for Cursive
Received 500,000 GPU hours on Isambard-AI through UK Sovereign AI Fund
European Tech Sovereignty: UK names first Sovereign AI investees- What does Cursive AI do?
- Cursive builds continuous-learning AI agents — systems that learn from ongoing interaction rather than a fixed training run — and received UK Sovereign AI Fund compute access in April 2026.Source: UK DSIT 16 April 2026
- What is a continuous-learning AI agent?
- An AI agent that adapts from ongoing interaction, staying current without expensive full retraining — suitable for dynamic enterprise or government environments.Source: UK DSIT 16 April 2026
- Which UK AI startups are backed by the Sovereign AI Fund?
- First tranche (April 2026): Cosine, Prima Mente, Cursive, Doubleword, Twig Bio, and Odyssey received compute access; Callosum received direct equity.Source: UK DSIT 16 April 2026
Background
Cursive was named among the first six investees of the UK Sovereign AI Fund on 16 April 2026, receiving 500,000 GPU hours on Isambard-AI . The company builds continuous-learning AI agents — systems that learn and adapt from ongoing interaction rather than being fixed after a single training run.
Continuous learning addresses a known limitation of standard large language models: they are trained on a fixed dataset and require expensive retraining to incorporate new information. Agents that learn continuously are better suited for dynamic enterprise and government environments where the information landscape changes daily. This capability is particularly relevant for classified or regulated environments where the agent must stay current without sending data to external Cloud training pipelines.
Like the other five Sovereign AI compute investees, Cursive also receives same-day super-priority visa decisions, ten free R&D visas, legal-fee cover for UK incorporation, and access to government procurement pipelines .
